Skip to main content
. 2018 Oct 26;37:144–157. doi: 10.1016/j.ebiom.2018.10.046

Fig. 5.

Fig. 5

Patient genetic profile obtained in the METABRIC study. a) The graph shows the different genetic alterations identified in patients in the 16 genes that were significantly different in the model. b) Genetic network showing the main interactions between the affected genes and their intermediates. Drugs used in clinical trials targeting these pathways are also included.